Status:
COMPLETED
Chloroquine and Amodiaquine for Treatment of Malaria in Children
Lead Sponsor:
Bandim Health Project
Conditions:
Malaria, Falciparum
Eligibility:
All Genders
Up to 15 years
Phase:
PHASE4
Brief Summary
This study will evaluate the efficacy of the treatment recommended by the National Malaria Programme in Guinea-Bissau as compared to a higher dose of chloroquine and to another anti-malarial drug, amo...
Detailed Description
This study compares treatment of uncomplicated malaria in children in Guinea-Bissau as recommended by the national malaria programme (chloroquine in a total dose of 25 mg/kg), either with a total dose...
Eligibility Criteria
Inclusion
- Patients \< 15 years of age presenting at Bandim Health Centre
- Symptoms suggestive of malaria
- At least 20 P. falciparum parasites per 200 leukocytes in a thick film
- Live in Bandim (to enable follow-up)
Exclusion
- Severely ill children considered needing the services of a hospital by the medical doctor in charge
- Stated medication with other antimalarials within one week prior to treatment
- Previous idiosyncratic reactions to any of the study drugs
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
End Date :
May 1 2004
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT00137514
Start Date
March 1 2001
End Date
May 1 2004
Last Update
April 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Apartado 861, Bissau Region, Guinea-Bissau